Examkin

Soru

Zorluk: Çok zorPsychopharmacology and Psychological Therapies

A 2828-year-old woman with a history of severe bipolar I disorder presents to the clinic for an initial prenatal visit at 66 weeks gestation. She is currently stable on lithium carbonate and has not experienced a manic episode in 33 years. However, she has a history of life-threatening manic episodes with psychotic features whenever she has attempted to discontinue her medication in the past. She wishes to continue her pregnancy. Arrange the following steps in the optimal pharmacological and obstetric management of this patient in chronological order, from the first trimester through the immediate postpartum period.

  1. 1Counsel the patient on the risk of Ebstein anomaly and continue the current lithium regimen to prevent mood destabilization.
  2. 2Order a targeted fetal echocardiogram at 1818 to 2222 weeks gestation to screen for congenital cardiac defects.
  3. 3Increase the frequency of serum lithium level monitoring to weekly during the third trimester and adjust the dose as needed.
  4. 4Withhold the administration of lithium at the onset of active labor to prevent maternal toxicity during massive fluid shifts.
  5. 5Reinstitute the pre-pregnancy lithium dose immediately following delivery to prevent postpartum manic relapse.

Cevap

The correct sequence for managing a pregnant patient on lithium with severe bipolar disorder is: First, continue lithium and counsel on teratogenic risks at the initial visit; second, perform a fetal echocardiogram at 1818 to 2222 weeks; third, increase monitoring frequency to weekly in the third trimester; fourth, withhold lithium at the onset of active labor; and finally, resume the pre-pregnancy dose immediately postpartum.
The optimal management of a pregnant patient with severe bipolar I disorder on lithium involves a delicate chronological balance of teratogenic risk assessment and physiological changes. At 66 weeks gestation, the first step is to counsel the patient about the absolute risk of Ebstein anomaly and continue the medication, as abrupt discontinuation carries a catastrophic risk of relapse. During the second trimester (1818 to 2222 weeks), a targeted fetal echocardiogram must be ordered to screen for structural cardiac defects resulting from first-trimester exposure. As the pregnancy progresses into the third trimester, the maternal glomerular filtration rate (GFR) and plasma volume reach peak levels, increasing lithium clearance; therefore, monitoring frequency must be increased to weekly, and the dose is often adjusted upward. At the onset of active labor, massive fluid shifts and potential dehydration can rapidly decrease lithium clearance and precipitate acute toxicity, requiring the medication to be temporarily withheld. Finally, immediately following delivery, maternal GFR normalizes rapidly. The patient must be quickly returned to her pre-pregnancy lithium dose to avoid toxicity from the higher third-trimester dose while providing critical prophylaxis against the extremely high risk of postpartum mania.

Adım Adım Çözüm

1
Determine first trimester management for severe bipolar disorder.
Counsel on the risk of Ebstein anomaly and continue the medication (item_1).
The absolute risk of Ebstein anomaly is relatively low (roughly 11 in 1,0001,000 to 11 in 2,0002,000), whereas a manic relapse off medication poses a severe threat to both mother and fetus.
2
Identify the appropriate obstetric screening for lithium exposure.
Schedule a targeted fetal echocardiogram (item_2).
Fetal cardiac development and structural anomalies caused by early lithium exposure can be optimally assessed between 1818 and 2222 weeks gestation.
3
Adjust management for late-pregnancy physiological changes.
Increase lithium monitoring to weekly in the third trimester (item_3).
Peak increases in maternal blood volume and glomerular filtration rate occur in the third trimester, leading to increased renal clearance of lithium and potential subtherapeutic levels.
4
Determine appropriate management during delivery.
Withhold lithium during active labor (item_4).
Massive fluid shifts, blood loss, and dehydration during labor can rapidly concentrate serum lithium, risking acute maternal toxicity.
5
Determine immediate postpartum management.
Resume the pre-pregnancy dose immediately after delivery (item_5).
Maternal GFR rapidly normalizes postpartum. Returning to the pre-pregnancy dose prevents toxicity while protecting against the very high risk of postpartum mania in bipolar I disorder.

Anahtar Kavram

The management of lithium therapy in pregnancy involves continuing the drug in severe bipolar disorder, screening for Ebstein anomaly via second-trimester fetal echocardiography, adjusting for third-trimester GFR increases, withholding during labor to prevent toxicity, and immediately resuming pre-pregnancy doses postpartum.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Psychopharmacology and Psychological Therapies

Bu konudan daha fazla soru